Tags

Type your tag names separated by a space and hit enter

The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
Dermatol Ther. 2020 Jul; 33(4):e13524.DT

Links

PMC Free PDF

Authors+Show Affiliations

Shah M
Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Sachdeva M
Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Dodiuk-Gad RP
Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Department of Dermatology, Ha'emek Medical Center, Afula, Israel. Ruth and Bruce Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.

MeSH

AntimalarialsBetacoronavirusCOVID-19ComorbidityCoronavirus InfectionsHumansHydroxychloroquinePandemicsPneumonia, ViralSARS-CoV-2Skin DiseasesCOVID-19 Drug Treatment

Pub Type(s)

Letter

Language

eng

PubMed ID

32383251

Citation

Shah, Monica, et al. "The Impact of Hydroxychloroquine Shortages On Patients With Dermatological Conditions During COVID-19 Pandemic." Dermatologic Therapy, vol. 33, no. 4, 2020, pp. e13524.
Shah M, Sachdeva M, Dodiuk-Gad RP. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic. Dermatol Ther. 2020;33(4):e13524.
Shah, M., Sachdeva, M., & Dodiuk-Gad, R. P. (2020). The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic. Dermatologic Therapy, 33(4), e13524. https://doi.org/10.1111/dth.13524
Shah M, Sachdeva M, Dodiuk-Gad RP. The Impact of Hydroxychloroquine Shortages On Patients With Dermatological Conditions During COVID-19 Pandemic. Dermatol Ther. 2020;33(4):e13524. PubMed PMID: 32383251.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic. AU - Shah,Monica, AU - Sachdeva,Muskaan, AU - Dodiuk-Gad,Roni P, Y1 - 2020/06/05/ PY - 2020/4/17/received PY - 2020/4/28/revised PY - 2020/4/30/accepted PY - 2020/5/10/pubmed PY - 2020/11/26/medline PY - 2020/5/9/entrez SP - e13524 EP - e13524 JF - Dermatologic therapy JO - Dermatol Ther VL - 33 IS - 4 SN - 1529-8019 UR - https://www.unboundmedicine.com/medline/citation/32383251/The_impact_of_hydroxychloroquine_shortages_on_patients_with_dermatological_conditions_during_COVID_19_pandemic_ DB - PRIME DP - Unbound Medicine ER -